Insights

Loading spinner
Gathering insights about Palladio Biosciences, Inc., a Centessa company

Palladio Biosciences, Inc., a Centessa company Tech Stack

Palladio Biosciences, Inc., a Centessa company uses 8 technology products and services including WP Rocket, WordPress, Font Awesome, and more. Explore Palladio Biosciences, Inc., a Centessa company's tech stack below.

  • WP Rocket
    Caching
  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • Twemoji
    Font Scripts
  • Atlassian Jira Issue Collector
    Issue Trackers
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • GoDaddy
    Web Hosting

Media & News

Palladio Biosciences, Inc., a Centessa company's Email Address Formats

Palladio Biosciences, Inc., a Centessa company uses at least 1 format(s):
Palladio Biosciences, Inc., a Centessa company Email FormatsExamplePercentage
FLast@palladiobio.comJDoe@palladiobio.com
36%
Last@palladiobio.comDoe@palladiobio.com
14%
FLast@palladiobio.comJDoe@palladiobio.com
36%
Last@palladiobio.comDoe@palladiobio.com
14%

Frequently Asked Questions

Where is Palladio Biosciences, Inc., a Centessa company's headquarters located?

Minus sign iconPlus sign icon
Palladio Biosciences, Inc., a Centessa company's main headquarters is located at 5 Walnut Grove Drive, Suite 120. The company has employees across 1 continents, including North America.

What is Palladio Biosciences, Inc., a Centessa company's official website and social media links?

Minus sign iconPlus sign icon
Palladio Biosciences, Inc., a Centessa company's official website is palladiobio.com and has social profiles on LinkedIn.

What is Palladio Biosciences, Inc., a Centessa company's SIC code NAICS code?

Minus sign iconPlus sign icon
Palladio Biosciences, Inc., a Centessa company's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Palladio Biosciences, Inc., a Centessa company have currently?

Minus sign iconPlus sign icon
As of December 2025, Palladio Biosciences, Inc., a Centessa company has approximately 20 employees across 1 continents, including North America. Key team members include Chief Business Officer: L. H.Chief Financial Officer Head Of Qa: M. T.Vice President Clinical Operations, Palladio Biosciences: E. R.. Explore Palladio Biosciences, Inc., a Centessa company's employee directory with LeadIQ.

What industry does Palladio Biosciences, Inc., a Centessa company belong to?

Minus sign iconPlus sign icon
Palladio Biosciences, Inc., a Centessa company operates in the Biotechnology Research industry.

What technology does Palladio Biosciences, Inc., a Centessa company use?

Minus sign iconPlus sign icon
Palladio Biosciences, Inc., a Centessa company's tech stack includes WP RocketWordPressFont AwesomeTwemojiAtlassian Jira Issue CollectorPHPYoast SEOGoDaddy.

What is Palladio Biosciences, Inc., a Centessa company's email format?

Minus sign iconPlus sign icon
Palladio Biosciences, Inc., a Centessa company's email format typically follows the pattern of FLast@palladiobio.com. Find more Palladio Biosciences, Inc., a Centessa company email formats with LeadIQ.

How much funding has Palladio Biosciences, Inc., a Centessa company raised to date?

Minus sign iconPlus sign icon
As of December 2025, Palladio Biosciences, Inc., a Centessa company has raised $20M in funding. The last funding round occurred on Sep 25, 2020 for $20M.

When was Palladio Biosciences, Inc., a Centessa company founded?

Minus sign iconPlus sign icon
Palladio Biosciences, Inc., a Centessa company was founded in 2015.

Palladio Biosciences, Inc., a Centessa company

Biotechnology ResearchPennsylvania, United States11-50 Employees

Palladio Biosciences, Inc., is a Centessa company.  Our first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADPKD causes numerous fluid-filled cysts to grow in both kidneys.  It is a life-limiting, chronic and progressive disease.  It is the 4th leading cause of kidney failure and carries significant financial and emotional burden, affecting entire families.  
There is no cure for PKD.  We are developing lixivaptan as a safe and effective agent to be used chronically to prevent the progression of PKD.

Section iconCompany Overview

Headquarters
5 Walnut Grove Drive, Suite 120
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $20M

    Palladio Biosciences, Inc., a Centessa company has raised a total of $20M of funding over 2 rounds. Their latest funding round was raised on Sep 25, 2020 in the amount of $20M.

  • $1M$10M

    Palladio Biosciences, Inc., a Centessa company's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $20M

    Palladio Biosciences, Inc., a Centessa company has raised a total of $20M of funding over 2 rounds. Their latest funding round was raised on Sep 25, 2020 in the amount of $20M.

  • $1M$10M

    Palladio Biosciences, Inc., a Centessa company's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.